vs

Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and AgEagle Aerial Systems Inc. (UAVS). Click either name above to swap in a different company.

Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.0M, roughly 2.0× AgEagle Aerial Systems Inc.). On growth, Opus Genetics, Inc. posted the faster year-over-year revenue change (-10.2% vs -40.0%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs -17.9%).

Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.

Elbit Systems Ltd. is an Israel-based international military technology company and defense contractor. Founded in 1966 by Elron, Elbit Systems is the primary provider of the Israeli military's land-based equipment and unmanned aerial vehicles. It is an important company within the defense industry of Israel.

IRD vs UAVS — Head-to-Head

Bigger by revenue
IRD
IRD
2.0× larger
IRD
$3.9M
$2.0M
UAVS
Growing faster (revenue YoY)
IRD
IRD
+29.9% gap
IRD
-10.2%
-40.0%
UAVS
Faster 2-yr revenue CAGR
IRD
IRD
Annualised
IRD
50.3%
-17.9%
UAVS

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
IRD
IRD
UAVS
UAVS
Revenue
$3.9M
$2.0M
Net Profit
$-2.6M
Gross Margin
38.5%
Operating Margin
-160.1%
Net Margin
-132.7%
Revenue YoY
-10.2%
-40.0%
Net Profit YoY
53.0%
24.4%
EPS (diluted)
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRD
IRD
UAVS
UAVS
Q4 25
$3.9M
Q3 25
$3.1M
$2.0M
Q2 25
$2.9M
$4.2M
Q1 25
$4.4M
$3.6M
Q4 24
$4.3M
$2.8M
Q3 24
$3.9M
$3.3M
Q2 24
$1.1M
$3.4M
Q1 24
$1.7M
$3.9M
Net Profit
IRD
IRD
UAVS
UAVS
Q4 25
Q3 25
$-17.5M
$-2.6M
Q2 25
$-7.4M
$-1.3M
Q1 25
$-8.2M
$7.1M
Q4 24
$-22.3M
Q3 24
$-7.5M
$-3.5M
Q2 24
$-7.8M
$-2.9M
Q1 24
$-7.1M
$-6.3M
Gross Margin
IRD
IRD
UAVS
UAVS
Q4 25
Q3 25
38.5%
Q2 25
55.7%
Q1 25
58.5%
Q4 24
40.6%
Q3 24
49.7%
Q2 24
45.8%
Q1 24
50.2%
Operating Margin
IRD
IRD
UAVS
UAVS
Q4 25
Q3 25
-269.9%
-160.1%
Q2 25
-309.0%
-49.3%
Q1 25
-227.2%
-27.5%
Q4 24
-207.0%
Q3 24
-207.1%
-56.7%
Q2 24
-748.9%
-74.9%
Q1 24
-450.5%
-61.5%
Net Margin
IRD
IRD
UAVS
UAVS
Q4 25
Q3 25
-566.9%
-132.7%
Q2 25
-257.5%
-30.5%
Q1 25
-187.5%
193.5%
Q4 24
-791.9%
Q3 24
-194.6%
-105.3%
Q2 24
-698.3%
-86.4%
Q1 24
-415.3%
-162.2%
EPS (diluted)
IRD
IRD
UAVS
UAVS
Q4 25
Q3 25
$-0.25
$-0.09
Q2 25
$-0.12
$-0.32
Q1 25
$-0.24
$-0.09
Q4 24
$52.35
Q3 24
$-0.29
$-16.03
Q2 24
$-0.30
$-12.06
Q1 24
$-0.29
$-70.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRD
IRD
UAVS
UAVS
Cash + ST InvestmentsLiquidity on hand
$45.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$15.3M
$28.3M
Total Assets
$50.2M
$34.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRD
IRD
UAVS
UAVS
Q4 25
$45.1M
Q3 25
$30.8M
Q2 25
$32.4M
Q1 25
$41.8M
$3.8M
Q4 24
$30.3M
$3.6M
Q3 24
$36.6M
$265.1K
Q2 24
$41.4M
$977.2K
Q1 24
$47.2M
$822.9K
Total Debt
IRD
IRD
UAVS
UAVS
Q4 25
Q3 25
Q2 25
Q1 25
$420.4K
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IRD
IRD
UAVS
UAVS
Q4 25
$15.3M
Q3 25
$6.0M
$28.3M
Q2 25
$17.5M
$16.3M
Q1 25
$5.1M
$4.2M
Q4 24
$6.7M
$-5.7M
Q3 24
$34.3M
$6.2M
Q2 24
$40.6M
$8.1M
Q1 24
$46.1M
$9.1M
Total Assets
IRD
IRD
UAVS
UAVS
Q4 25
$50.2M
Q3 25
$36.1M
$34.5M
Q2 25
$38.7M
$23.2M
Q1 25
$48.2M
$20.2M
Q4 24
$36.9M
$20.6M
Q3 24
$40.4M
$22.0M
Q2 24
$44.8M
$22.8M
Q1 24
$51.8M
$23.2M
Debt / Equity
IRD
IRD
UAVS
UAVS
Q4 25
Q3 25
Q2 25
Q1 25
0.10×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRD
IRD
UAVS
UAVS
Operating Cash FlowLast quarter
$-35.3M
$-3.3M
Free Cash FlowOCF − Capex
$-3.3M
FCF MarginFCF / Revenue
-168.0%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRD
IRD
UAVS
UAVS
Q4 25
$-35.3M
Q3 25
$-6.2M
$-3.3M
Q2 25
$-10.3M
$-2.7M
Q1 25
$-9.0M
$-1.3M
Q4 24
$-25.6M
$-2.5M
Q3 24
$-5.1M
$-1.1M
Q2 24
$-7.3M
$-1.4M
Q1 24
$-5.7M
$-1.6M
Free Cash Flow
IRD
IRD
UAVS
UAVS
Q4 25
Q3 25
$-3.3M
Q2 25
$-2.8M
Q1 25
$-1.3M
Q4 24
$-2.5M
Q3 24
$-1.1M
Q2 24
$-1.4M
Q1 24
$-1.6M
FCF Margin
IRD
IRD
UAVS
UAVS
Q4 25
Q3 25
-168.0%
Q2 25
-65.7%
Q1 25
-35.8%
Q4 24
-89.7%
Q3 24
-32.7%
Q2 24
-42.5%
Q1 24
-40.5%
Capex Intensity
IRD
IRD
UAVS
UAVS
Q4 25
Q3 25
0.7%
Q2 25
0.3%
Q1 25
0.3%
Q4 24
0.5%
Q3 24
0.0%
Q2 24
0.4%
Q1 24
0.6%
Cash Conversion
IRD
IRD
UAVS
UAVS
Q4 25
Q3 25
Q2 25
Q1 25
-0.18×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRD
IRD

Segment breakdown not available.

UAVS
UAVS

Drones Segment$1.1M54%
Other$912.5K46%

Related Comparisons